Analystreport

Horizon Therapeutics Public Limited (NASDAQ: HZNP) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.

Horizon Therapeutics Public Limited Company - Ordinary Shares  (HZNP) 
Last horizon therapeutics public limited company - ordinary shares earnings: 2/26 07:00 am Check Earnings Report